AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET ANALYSIS

Automated Antimicrobial Susceptibility Testing Market – Insights

Automated antimicrobial susceptibility testing is extensively used to achieve minimum inhibitory concentration (MIC) results using an antimicrobial susceptibility testing system, which offers flexible, customizable testing options to accommodate laboratories of all sizes. Antimicrobial susceptibility testing (AST) aims to ensure that suitable antibiotics are prescribed to individuals by monitoring inhibition zone of antibiotics and emergence of resistant pathogens in infected individuals. Information on local patterns of antimicrobial susceptibility can be collected using antimicrobial susceptibility testing, so that policies guiding the therapy can be based on current data on local resistance trends or institutional antibiogram.

The global automated antimicrobial susceptibility testing market size was valued at US$ 1,295.5 million in 2018 and is expected to witness a CAGR of 8.9% over the forecast period (2018 – 2026).

Global Automated Antimicrobial Susceptibility Testing Market Share (%) Analysis, By Product Type, 2018

To learn more about this report, request a free sample copy

Source: Coherent Market Insights Analysis (2019)

Emergence of multidrug resistance worldwide is expected to drive growth of the automated antimicrobial susceptibility testing market

Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, and others among the global population is expected to result in increasing adoption of antimicrobial susceptibility testing to reduce the resistance exposure during the forecast period. For instance, according to the World Health Organization (WHO), in 2014, there were around 480,000 new cases of multidrug-resistant tuberculosis (MDR-TB), a form of tuberculosis that is resistant to the two most powerful anti-TB drugs. Among these, only around 123,000 cases were detected and reported.

Moreover, increasing number of product launches is also expected to highly contribute to the automated antimicrobial susceptibility testing market growth. For instance, in March 2016, Becton, Dickinson and Company launched the new BD Phoenix M50 ID/AST system, which helps to deliver the same rapid, accurate, and cost-effective testing as the legacy BD Phoenix 100, within a small footprint.

Automated Antimicrobial Susceptibility Testing Market - Restraints

Challenges in automated antimicrobial susceptibility testing include stringent rules and regulations from regulatory bodies, which hinders growth of the automated antimicrobial susceptibility testing market size. For instance, in the European Union, antimicrobial susceptibility testing (AST) systems are regulated by the Directive 98/79/EC (IVD directive), which was changed in 2017 with the introduction of the Regulation 2017/746 of the European Parliament and of the Council. It requires design, development, and manufacturing to be performed under a quality system according to ISO 13485.

Automated Antimicrobial Susceptibility Testing Market - Regional Insights

On the basis of region, the global automated antimicrobial susceptibility testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global automated antimicrobial susceptibility testing market during the forecast period, owing to development of new antimicrobial testing procedures and increasing awareness among people regarding antimicrobial resistance (AMR). For instance, in April 2018, the U.S. Food and Drug Administration approved Thermo Scientific Sensititre ID/AST System, the first to offer delafloxacin and meropenem/vaborbactam on IVD-labeled, microbroth dilution susceptibility plates. The antimicrobials are currently available in the U.S. on Sensititre custom plates and are expected be available soon in new standard formats.

Asia Pacific is expected to witness rapid growth in the automated antimicrobial susceptibility testing market, owing to high prevalence of microbial infections and increasing consumption of antibiotics, eventually developing resistance among the population. For instance, according to a 2014 WHO report, multidrug-resistant tuberculosis rates were high in India, especially among those who were previously treated and treatment for the disease is generally limited.

Global Automated Antimicrobial Susceptibility Testing Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2026

To learn more about this report, request a free sample copy

 Source: Coherent Market Insights Analysis (2019)

Automated Antimicrobial Susceptibility Testing Market - Competitive Landscape

Key players operating in the global automated antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.